FDA Adverse Event Malfunction Summary report: N

TRUEMETRIX

MDR report key: 6784442 · Received August 10, 2017

Report

Report Number
1000113657-2017-01536
Event Type
Malfunction
Date Received
August 10, 2017
Date of Event
July 19, 2017
Report Date
August 10, 2017
Manufacturer
TRIVIDIA HEALTH, INC.
Product Code
NBW
UDI-DI
00021292006068
PMA / PMN Number
K140100
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). RETURNED METER EVALUATED WITH NO DEFECT FOUND. TEST STRIPS NOT RETURNED FOR EVALUATION. MOST LIKELY UNDERLYING ROOT CAUSE: MLC-20-USER'S TEST STRIP HAD POOR STORAGE. (B)(4).

Description of Event or Problem · 1

CONSUMER REPORTED COMPLAINT FOR ERRATIC AND HIGH BLOOD GLUCOSE TEST RESULTS. WIFE IS CALLING ON BEHALF OF THE CUSTOMER. THE CUSTOMER IS CONCERNED WITH TESTS RESULTS FROM BACK TO BACK BLOOD TESTS OF 193 AND 166 MG/DL AND OF HIGH RESULT OF 199 MG/DL. THE CUSTOMER'S EXPECTED FASTING BLOOD GLUCOSE TEST RESULT RANGE IS 100 - 130 MG/DL. THE CUSTOMER FEELS WELL AND DID NOT REPORT ANY SYMPTOMS. MEDICAL ATTENTION IS NOT REPORTED AS A RESULT OF THE ACTUAL BLOOD GLUCOSE RESULTS. DURING THE CALL ON (B)(6) 2017, A BACK TO BACK BLOOD TEST WAS NOT PERFORMED BY THE CUSTOMER. THE PRODUCT IS NOT STORED ACCORDING TO SPECIFICATION; CUSTOMER IS STORING STRIPS IN A METAL CAN IN THE CLOSET WITH NO CENTRAL AIR CONDITIONING IN THE HOME. THE TEST STRIP LOT MANUFACTURER'S EXPIRATION DATE IS 09/16/2018 AND OPEN VIAL DATE AT TIME OF CALL IS ONE WEEK. THE METER MEMORY WAS REVIEWED FOR PREVIOUS TEST RESULT HISTORY: 145MG/DL , (B)(6) 2017, 04:48 PM, FASTING: YES; 193MG/DL, (B)(6) 2017, 04:46 PM, FASTING: YES; 99MG/DL, (B)(6) 2017, 04:45 PM, FASTING: YES; 166MG/DL, (B)(6) 2017, 04:43 PM, FASTING: YES; 199MG/DL, (B)(6) 2017, 12:00AM, FASTING: YES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
565479 TRUEMETRIX BLOOD GLUCOSE SYSTEM NBW TRIVIDIA HEALTH, INC. TRUEMETRIX MU2392 00021292006068

Patients

Seq Age Sex Outcome Treatment
1 0 YR